2022
DOI: 10.1227/neu.0000000000002236
|View full text |Cite
|
Sign up to set email alerts
|

Complementary and Alternative Medicine for Gliomas: Systematic Review and Critical Appraisal of Current Literature

Abstract: BACKGROUND:Many patients with glioma and their caregivers seek complementary and alternative medicine (CAM) methods to comfort themselves, cope with cancer medication side effects, and feel they are taking control of their disease.OBJECTIVE:To summarize existing evidence on safety and efficacy of CAM treatments for gliomas.METHODS:We performed an exhaustive electronic literature search for in vitro, animal, and clinical studies (English language, all years available) on CAM modalities for gliomas.RESULTS:A tot… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
3
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
2
1
1

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(3 citation statements)
references
References 42 publications
0
3
0
Order By: Relevance
“…To ensure patient safety, physicians must know whether patients use natural remedies or other CT modalities that might produce adverse effects (26)(27)(28)(29). Second, the experienced bene ts of patients´ CT use may remain undiscussed in clinical encounters.…”
Section: Introductionmentioning
confidence: 99%
“…To ensure patient safety, physicians must know whether patients use natural remedies or other CT modalities that might produce adverse effects (26)(27)(28)(29). Second, the experienced bene ts of patients´ CT use may remain undiscussed in clinical encounters.…”
Section: Introductionmentioning
confidence: 99%
“…The investigators shine a light on a corner of neuro-oncology that is often overlooked. Kerezoudis et al 10 also note that a patient with a glioma values the positive sense of control over their disease.…”
mentioning
confidence: 99%
“…In this issue, Kerezoudis et al 10 reported a comprehensive survey of CAM used by patients with glioma. The comprehensive survey covers >20 years, >300 unique studies, and covering the gamut from in vitro to animal and clinical studies.…”
mentioning
confidence: 99%